Clinical Trial: A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy Adults
Study Type: INTERVENTIONAL
Official Title: An Open-label Study to Determine the Effect of Oral Doses of KP-001 on Metformin and Midazolam Pharmacokinetics After a Single Oral Administration and to Determine the Effect of Clarithromycin on KP-0
Brief Summary:
The purpose of this study is to determine the Effects of KP-001 on Metformin (a substrate of MATE1) and Midazolam (a substrate of CYP3A4) Pharmacokinetics and the Effect of Clarithromycin (potent CYP3A4/P-gp Inhibitor) on KP-001 Pharmacokinetics in Healthy Adult Participants.The study will also evaluate the safety and tolerability of KP-001 with and without a single dose or multiple doses of an interaction drug.The study comprises 3 parts.Participants will stay in the Clinical Unit during the study, depending…
Read more